Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ZCL278
Cat. No.:
OB0225LY-0056
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
ZCL278 is a small molecule with inhibitory effects that targets specific signaling pathways (e.g., the PI3K/Akt pathway).
Synonym:
ZCL 278; 587841-73-4; 2-(4-Bromo-2-chlorophenoxy)-N-(4-(N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl)phenylcarbamothioyl)acetamide; 2-(4-Bromo-2-chlorophenoxy)-N-((4-(N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl)phenyl)carbamothioyl)acetamide; 2-(4-Bromo-2-chlorophenoxy)-N-[[4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]phenyl]carbamothioyl]acetamide
CAS No.:
587841-73-4
Compound CID:
1791111
Formula:
C21H19BrClN5O4S2
Formula Weight:
584.89
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ZCL278 can be used to study apoptosis, proliferation and signaling mechanisms.
Library Information
Targets:
GTPase superfamily; CDK family
Receptors:
Cdc42 GTPase; Ras
Pathways:
Cell cycle/Checkpoint; MAPK; GPCR/G protein
Plate Number:
AOCL-1
Plate Location:
f8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
40 mg/mL; 68.39 mM
